Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
H. Yildirim, M. Metintas, G. Ak, S. Erginel, F. Alatas (Eskisehir, Turkey). Predictors of trapped lung in patients with malignant pleural effusions; comparison of pleural elastance and pleural fluid pH. Eur Respir J 2009; 34: Suppl. 53, 1934

Member's Comments

No comment yet.

Related content which might interest you: Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003 Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007 Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Incidence and aetiology of eosinophilic pleural effusion Source: Eur Respir J 2009; 34: 1111-1117 Year: 2009 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Evaluation of patients with pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 247s Year: 2004 Diagnostic approach in a patient with pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131 Year: 2002 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Ideal volume sampling in the diagnosis of malignant pleural effusions Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions Year: 2012 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Prognostic features of residual pleural thickening after parapneumonic pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 605s Year: 2002 Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Closed pleural brushing in the diagnosis of malignant pleural effusions Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008